Keplat (Ketoprofen)

Ketoprofen works by non‑selectively inhibiting the cyclooxygenase enzymes COX‑1 and COX‑2, which reduces the synthesis of prostaglandins—key mediators of inflammation, pain and fever. Lower prostaglandin levels diminish the inflammatory response and alleviate pain at the site of application.

The appropriate dose of Keplat is determined by the prescribing healthcare professional based on the patient’s condition, severity of symptoms, and overall health status. The prescriber will select the number of patches, size and duration of therapy that best suit the individual’s therapeutic needs.

Safety data for ketoprofen transdermal patches in pregnancy and lactation are limited. Because NSAIDs can affect fetal development and may be excreted in breast milk, the product should be used only if clearly needed and after a risk‑benefit assessment by a qualified healthcare provider.

To order Keplat, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Keplat delivers ketoprofen directly through the skin, offering targeted pain relief with potentially lower systemic exposure compared with oral NSAIDs such as ibuprofen or naproxen. This route can reduce gastrointestinal side effects but still carries typical NSAID risks, including cardiovascular and renal considerations.

Keplat patches should be stored at room temperature, below 25 °C, in their original, sealed packaging. Protect them from moisture, direct sunlight and extreme temperatures. Keep the product out of reach of children and do not use patches that are damaged or past their expiration date.

The patch is applied to clean, dry, hair‑free skin on the affected area. Press firmly for several seconds to ensure good contact, then cover with the supplied protective film if required. The patch remains in place for the duration prescribed, after which it should be removed, folded inward and disposed of safely.

Serious adverse reactions can include severe allergic responses such as angio‑edema or anaphylaxis, skin disorders like Stevens‑Johnson syndrome, gastrointestinal ulceration or bleeding, and renal or hepatic impairment. Patients should seek immediate medical attention if they experience swelling of the face, persistent stomach pain, blood in stools or urine, or sudden loss of kidney function.

Keplat should be avoided in individuals with known hypersensitivity to ketoprofen or any other NSAIDs, those with active gastrointestinal ulcer disease, severe renal or hepatic impairment, and patients who have experienced previous serious cardiovascular events related to NSAID use. Consultation with a healthcare professional is essential before initiating therapy.